Testing effectiveness (Phase 2)Study completedNCT01941407What this trial is testingFirst Line Metastatic Breast Cancer Treatment (ESMERALDA)Who this might be right forMetastatic Breast Cancer ARCAGY/ GINECO GROUP 61
Early research (Phase 1)Study completedNCT01009437What this trial is testingRitonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast CancerWho this might be right forBreast Cancer Masonic Cancer Center, University of Minnesota 28
Not applicableLooking for participantsNCT06106477What this trial is testingImpact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for Women With HR+/HER2- Early Breast CancerWho this might be right forBreast Cancer Medical College of Wisconsin 20
Not applicableLooking for participantsNCT06050109What this trial is testingThe Benefits of Continued Use of Ovarian Function Suppression After 5 YearsWho this might be right forBreast Cancer FemaleEndocrine Therapy Hongmei Zheng, PhD 1,200
Not applicableActive Not RecruitingNCT03697577What this trial is testingCDK and Body Composition StudyWho this might be right forBreast Cancer Montefiore Medical Center 30
Large-scale testing (Phase 3)Looking for participantsNCT06757634What this trial is testingPhase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)Who this might be right forBreast Cancer Celcuity Inc 1,180
Not applicableUnknownNCT05169853What this trial is testingProgrammed Death-Ligand1 Expression in Her-2 Positive and Triple Negative Breast CancerWho this might be right forTriple Negative Breast CancerHER2-positive Breast Cancer Ain Shams University 80
Large-scale testing (Phase 3)Not Yet RecruitingNCT07005557What this trial is testingChemo-free in Older (≥65) Node-Positive ER+/HER2- Breast CancerWho this might be right forBreast CancerAdjuvant Therapy Fudan University 1,244
Very early researchNot Yet RecruitingNCT07671092What this trial is testingImaging Study in Metastatic UC, HR+ and HER2- Breast Cancer, TNBC, and NSCLCWho this might be right forMetastatic Urothelial CarcinomaBreast CancerTNBC - Triple-Negative Breast Cancer+2 more RayzeBio, Inc. 40
Large-scale testing (Phase 3)Looking for participantsNCT05950945What this trial is testingTrastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast CancerWho this might be right forBreast Cancer Daiichi Sankyo 250
Not applicableStudy completedNCT06307457What this trial is testingHR+/HER2- Metastatic Breast Cancer Patients Treated With Palbociclib Together With an Aromatase Inhibitor From 2017 to 2023 in Denmark.Who this might be right forBreast Cancer Pfizer 604
Testing effectiveness (Phase 2)Looking for participantsNCT04090567What this trial is testingOlaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast CancerWho this might be right forAdvanced Breast CarcinomaAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8+12 more M.D. Anderson Cancer Center 60
Testing effectiveness (Phase 2)WithdrawnNCT06938711What this trial is testingA Rollover Protocol of Elacestrant, in Combination With Onapristone, for Patients With ER+, PR+, HER2- Advanced or Metastatic Breast CancerWho this might be right forBreast Cancer Context Therapeutics Inc.
Not applicableStudy completedNCT06655545What this trial is testing18F-fluoroestradiol (18F-FES) PET/CT Guided First-line Treatment for HR+/HER2- Metastatic Breast Cancer PatientsWho this might be right forBreast Cancer Fudan University 473
Testing effectiveness (Phase 2)UnknownNCT03560856What this trial is testingA Biomarker Study of Palbociclib + Fulvestrant for Second, and Third Line of Postmenopausal Women With hr+/her2- Advanced Breast CancerWho this might be right forBreast CancerHR+/HER2-negative Breast CancerMetastasis Assistance Publique - Hôpitaux de Paris 54
Testing effectiveness (Phase 2)UnknownNCT04282031What this trial is testingBPI-1178 in Patients With Advanced Solid Tumor and HR+/HER2- Breast CancerWho this might be right forAdvanced Solid TumorHR+/HER2- Breast Cancer Beta Pharma (Suzhou) Co., Ltd. 224
Testing effectiveness (Phase 2)Active Not RecruitingNCT02955394What this trial is testingPreoperative Fulvestrant With or Without Enzalutamide in ER+/Her2- Breast CancerWho this might be right forBreast Cancer University of Colorado, Denver 61
Testing effectiveness (Phase 2)Active Not RecruitingNCT02876107What this trial is testingCarboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast CancerWho this might be right forBreast CarcinomaBreast LumpEdema+8 more M.D. Anderson Cancer Center 42
Not applicableUnknownNCT03617341What this trial is testingBrain Monitoring for High Risk of Brain Metastases in Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer With HER2 PositiveTriple Negative Breast Cancer Yonsei University 200
Large-scale testing (Phase 3)Study completedNCT01547741What this trial is testingDocetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast CancerWho this might be right forBreast Cancer NSABP Foundation Inc 4,242